| TO: | Honorable John Carona, Chair, Senate Committee on Business & Commerce |
| FROM: | Ursula Parks, Director, Legislative Budget Board |
| IN RE: | SB992 by Taylor (Relating to misrepresentations in connection with certain drug testing devices or equipment; providing penalties.), Committee Report 1st House, Substituted |
The bill would amend the Penal Code to prohibit a manufacturer or seller of drug testing equipment from representing that the equipment is capable of drug testing unless it has been approved by the United States Food and Drug Administration. It is anticipated that any costs associated with the bill could be absorbed within existing resources.
The bill would classify any violation of the provision of the bill as a Class C misdemeanor and punishable by a fine of not more than $500. It is anticipated that any costs associated with enforcement and prosecution could be absorbed within existing resources. It is also anticipated that any revenue from fines imposed and collected would not have a significant fiscal impact.
| Source Agencies: | 302 Office of the Attorney General
|
| LBB Staff: | UP, KKR, RB, EP, JM
|